General MedicationsINJECTIONGeneric
ACCRETROPIN
SOMATROPIN
Standard Dose
5MG/ML (5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ACCRETROPIN is listed in Drugs@FDA under application 021538 (BLA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SOMATROPIN Form and strength INJECTABLE;INJECTION - 5MG/ML (5MG/ML) Sponsor EMERGENT Submission history Latest submission status date: 2016-12-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview ACCRETROPIN is listed in Drugs@FDA under application 021538 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SOMATROPIN Form and strength INJECTABLE;INJECTION - 5MG/ML (5MG/ML) Sponsor EMERGENT Submission history Latest submission status date: 2016-12-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.